176 related articles for article (PubMed ID: 34955041)
1. An Intrahepatic Cholangiocarcinoma with Focal Rhabdoid Features and SMARCA4-Deficiency.
Minato H; Yoshikawa A; Katayanagi K; Kurumaya H; Kato K; Kitamura H
Int J Surg Pathol; 2022 Aug; 30(5):581-585. PubMed ID: 34955041
[TBL] [Abstract][Full Text] [Related]
2. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
3. ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications.
Xu W; Dong H; Ru G; Zhao M
Diagn Pathol; 2022 Feb; 17(1):22. PubMed ID: 35125107
[TBL] [Abstract][Full Text] [Related]
4. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
[TBL] [Abstract][Full Text] [Related]
5. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
Ramalingam P; Croce S; McCluggage WG
Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
[TBL] [Abstract][Full Text] [Related]
6. Loss of BRG1 (
Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
[TBL] [Abstract][Full Text] [Related]
7. SWI/SNF-deficient thoraco-pulmonary neoplasms.
Sesboue C; Le Loarer F
Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
[TBL] [Abstract][Full Text] [Related]
8. Case report: intrahepatic cholangiocarcinoma with rhabdoid transformation.
Honda M; Enjoji M; Sakai H; Yamamoto I; Tsuneyoshi M; Nawata H
J Gastroenterol Hepatol; 1996 Aug; 11(8):771-4. PubMed ID: 8872777
[TBL] [Abstract][Full Text] [Related]
9. Switch/Sucrose Non-Fermentable Complex-Deficient Rhabdoid Carcinoma of Stomach: A Rare Case Report and Literature Review.
Chen M; Yao X; Ping J; Shen H; Wei Y; Wang WL
Int J Surg Pathol; 2023 Oct; 31(7):1364-1374. PubMed ID: 36895105
[TBL] [Abstract][Full Text] [Related]
10. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
[TBL] [Abstract][Full Text] [Related]
11. Molecular features of primary hepatic undifferentiated carcinoma.
Tsai JH; Jeng YM; Lee CH; Liau JY
Mod Pathol; 2022 May; 35(5):680-687. PubMed ID: 34949765
[TBL] [Abstract][Full Text] [Related]
12. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract.
Agaimy A; Bertz S; Cheng L; Hes O; Junker K; Keck B; Lopez-Beltran A; Stöckle M; Wullich B; Hartmann A
Virchows Arch; 2016 Sep; 469(3):321-30. PubMed ID: 27339451
[TBL] [Abstract][Full Text] [Related]
14. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
[TBL] [Abstract][Full Text] [Related]
15. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
16. Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma: Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency.
Agaimy A; Cheng L; Egevad L; Feyerabend B; Hes O; Keck B; Pizzolitto S; Sioletic S; Wullich B; Hartmann A
Am J Surg Pathol; 2017 Feb; 41(2):253-262. PubMed ID: 27984237
[TBL] [Abstract][Full Text] [Related]
17. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.
Schneppenheim R; Frühwald MC; Gesk S; Hasselblatt M; Jeibmann A; Kordes U; Kreuz M; Leuschner I; Martin Subero JI; Obser T; Oyen F; Vater I; Siebert R
Am J Hum Genet; 2010 Feb; 86(2):279-84. PubMed ID: 20137775
[TBL] [Abstract][Full Text] [Related]
18. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
[TBL] [Abstract][Full Text] [Related]
19. Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion.
Zhou Y; Chen Y; Zhang X; Xu Q; Wu Z; Cao X; Shao M; Shu Y; Lv T; Lu C; Xie M; Wen T; Yang J; Shi Y; Bu H
Hepatology; 2021 Aug; 74(2):797-815. PubMed ID: 33650193
[TBL] [Abstract][Full Text] [Related]
20. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
Bookhout C; Bouldin TW; Ellison DW
Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]